SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-219686
Filing Date
2018-07-17
Accepted
2018-07-17 16:10:58
Documents
5
Period of Report
2018-07-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d540889d8k.htm 8-K 17973
2 EX-1.1 d540889dex11.htm EX-1.1 171879
3 EX-5.1 d540889dex51.htm EX-5.1 11343
4 GRAPHIC g540889g0717075155014.jpg GRAPHIC 1785
5 GRAPHIC g540889image001.jpg GRAPHIC 1875
  Complete submission text file 0001193125-18-219686.txt   207649
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 18956621
SIC: 2834 Pharmaceutical Preparations